Registration Options

Activity Dates: 05/08/2020 - 04/28/2023

Members can access this product for only $35. Log in or Join now!

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

Mood, anxiety, and substance-use disorders are among the most prevalent mental illnesses in the population. While several pharmacological treatments are available, not all patients are successfully treated with these agents. Recent studies suggest that psychedelic agents including psilocybin, lysergic acid diethylamide (LSD), ketamine, and 3,4-methylenedioxy-methamphetamine (MDMA) may be helpful adjunctive treatments for depression, anxiety, and substance use disorders. After this session, participants will be able to summarize the available literature and ongoing research in the use of psychedelic agents and individuals living with mental illness.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Sign in (or create a FREE account).
  • Register for this course. (sign in first)
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (sign in first)
  • Complete the evaluation at the end of the activity. (sign in first)
  • If necessary, complete the post-test retest no later than the closing activity date. (sign in first)
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (sign in first)

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Learning Objectives

  1. Describe the neurophysiology of psychedelic-induced states of mind and the relation between these brain states and healing mechanisms for anxiety, depression, and existential suffering.
  2. Summarize the available literature available on the use of psychedelics including psilocybin, lysergic acid diethylamide (LSD), ketamine, and 3,4-methylenedioxy-methamphetamine (MDMA).
  3. Evaluate the current place in therapy for use of psychedelic agents in individuals with mental illness.
  4. Discuss future directions of psychedelic research in psychiatry.

Continuing Education Credit and Disclosures

Activity Dates: 05/08/2020 - 04/28/2023
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-20-021-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.